Zotefoams plc (the 'Company')
Grant of share awards
The Company announces that on 20 May 2019 the Executive Directors were granted the following conditional awards over the Company's Ordinary Shares of 5p each under the terms of the Company's Long Term Incentive Plan 2017 ('LTIP'):
Name |
|
|
Number of shares |
D B Stirling |
Chief Executive Officer |
|
73,070 |
|
|
|
|
G C McGrath |
Chief Financial Officer |
|
48,352 |
The LTIP awards will vest on the third anniversary of the grant date subject to achieving the performance criteria detailed in the Company's Annual Report 2018. A holding period of two years following the vesting date will apply, such that the awards will not normally be released until the fifth anniversary of the grant date.
Further, on 20 May 2019 the Executive Directors were granted the following restricted share awards over the Company's Ordinary Shares of 5p each under the Company's Deferred Bonus Share Plan ('DBSP'):
Name |
|
|
Number of shares |
D B Stirling |
Chief Executive Officer |
|
2,677 |
|
|
|
|
G C McGrath |
Chief Financial Officer |
|
2,497 |
The DBSP awards will be released on the third anniversary of the grant date subject to satisfaction of service conditions.
The Notification of Dealing Form for each Executive Director can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Enquiries:
James Adams
Interim Company Secretary
Zotefoams plc
21 May 2019
Tel: 020 8664 1600
About Zotefoams plc:
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA, to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell® Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.
AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc
MuCell® is a registered trademark of Trexel Inc.
AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc
MuCell® is a registered trademark of Trexel Inc.
ZOTEFOAMS PLC
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
a) |
Name: David Stirling |
||||||
2. |
Reason for the notification |
||||||
a) |
Position/status: Chief Executive Officer |
||||||
b) |
Initial notification/Amendment: Initial notification |
||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
a) |
Name: Zotefoams plc |
||||||
b) |
LEI: 213800B6P256B5XN8D32 |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||||
b) |
Nature of the transaction: Award of performance shares under the Long Term Incentive Plan |
||||||
c) |
Price(s) and volume(s):
|
||||||
d) |
Aggregated information:
|
||||||
e) |
Date of the transaction: 20 May 2019 |
||||||
f) |
Place of the transaction: Outside a trading venue |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||||
b) |
Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan |
||||||
c) |
Price(s) and volume(s):
|
||||||
d) |
Aggregated information:
|
||||||
e) |
Date of the transaction: 20 May 2019 |
||||||
f) |
Place of the transaction: Outside a trading venue |
ZOTEFOAMS PLC
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
a) |
Name: Gary McGrath |
||||||
2. |
Reason for the notification |
||||||
a) |
Position/status: Chief Financial Officer |
||||||
b) |
Initial notification/Amendment: Initial notification |
||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
a) |
Name: Zotefoams plc |
||||||
b) |
LEI: 213800B6P256B5XN8D32 |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||||
b) |
Nature of the transaction: Award of performance shares under the Long Term Incentive Plan |
||||||
c) |
Price(s) and volume(s):
|
||||||
d) |
Aggregated information:
|
||||||
e) |
Date of the transaction: 20 May 2019 |
||||||
f) |
Place of the transaction: Outside a trading venue |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||||
b) |
Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan |
||||||
c) |
Price(s) and volume(s):
|
||||||
d) |
Aggregated information:
|
||||||
e) |
Date of the transaction: 20 May 2019 |
||||||
f) |
Place of the transaction: Outside a trading venue |